Sort
64,565 grants matching “drug discovery”
A DRUG DISCOVERY PARTNERSHIP FOR PERSONALIZED BREAST CANCER THERAPY
$1,264,312Xavier University Of Louisiana · · FY2011 · Department of Defense
Asymmetric nucleosome substrates to advance the study of the histone code
$1,264,176Marcus Cheek · Epicypher, Inc. · R44 · FY2025 · GM
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis
$1,264,156Hans-Willem E Snoeck · Columbia University Health Sciences · U01 · FY2021 · HL
Mid Southern Primary Care Networks Node
$1,264,138Li-Tzy T Wu · Duke University · UG1 · FY2017 · DA
Conduct Synthesis and Acquire Batches of Compounds for Subsequent Biological In Vitro and In Vivo Testing
$1,264,071Mark Middleton · Starks Associates, Inc. · N01 · FY2024 · AI
Stem cells for therapeutics discovery in genetic blood disorders
$1,264,005George Q Daley · Boston Children'S Hospital · U01 · FY2018 · HL
Basic Research Support for the CCR
$1,263,819Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Biased Mu-Opioid Receptor Analgesics to Prevent Overdose and Opioid Use Disorders
$1,263,814Lawrence C Kuo · Mebias Discovery, Inc. · UG3 · FY2019 · DA
Combinatorial Chemistry and Cancer Target
$1,263,757Scripps Research Institute · P01 · FY2004 · CA
Center for Interventional Oncology
$1,263,405Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2025 · CA
NAPS2 Continuation Genome Wide Association Study of Pancreatitis
$1,263,255David C Whitcomb · University Of Pittsburgh At Pittsburgh · R56 · FY2011 · DK
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis
$1,262,972Hans-Willem E Snoeck · Columbia University Health Sciences · U01 · FY2022 · HL
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis
$1,262,369Hans-Willem E Snoeck · Columbia University Health Sciences · U01 · FY2018 · HL
Preclinical Development of HIV-1 Vif Antagonists
$1,262,306Mario Stevenson · University Of Miami School Of Medicine · P01 · FY2013 · MH
Solvation modeling for next-gen biomolecule simulations
$1,262,138Kenneth A Dill · State University New York Stony Brook · RM1 · FY2023 · GM
SHAMLOO (STANDFORD UNIVERSITY) - MCSP-EXPLORATORY CHEMISTRY (EC)
$1,261,955Keith Barnes · Albany Molecular Research, Inc. · N01 · FY2023 · DA
Preclinical Mouse Models of Thyroid Cancer
$1,261,890Sheue-Yann Cheng · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Novel Tetracycyclines as Antimalarial Drugs
$1,261,780Paratek Pharmaceuticals · R42 · FY2005 · AI
Research Capacity Core
$1,261,756Kinfe Ken Redda · Florida Agricultural And Mechanical Univ · U54 · FY2024 · MD
Clinical Research in ALS & related disorders for Therapeutic Development (CREATE)
$1,261,491Michael Benatar · University Of Miami School Of Medicine · U54 · FY2015 · NS
Kinetic Biomarker for CLL Prognosis
$1,261,275Kinemed, Inc. · R44 · FY2005 · CA
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis
$1,261,011Hans-Willem E Snoeck · Columbia University Health Sciences · U01 · FY2019 · HL
MRI: Acquisition of a Multipole Wiggler for the LSU Synchrotron for Protein Crystallography, Tomography, X-ray Absorption, Radiology, and Microfabrication
$1,261,000Marcia Newcomer · Louisiana State University · · FY2009 · MPS
Discovery, characterization and preclinical development of pro-neurogenic drugs
$1,260,917Steven L McKnight · Ut Southwestern Medical Center · R01 · FY2010 · MH
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
$1,260,626Steven Hou · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA